Knight Therapeutics Inc

GUD

Company Profile

  • Business description

    Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceuticalproducts. and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets. The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically, the company generates revenue from Brazil, Canada, Colombia, Argentina, Mexico, Rest of LATAM, and Others, with the majority revenue generated from the Brazil region.

  • Contact

    100 Alexis Nihon Boulevard
    Suite 600
    Saint-LaurentQCH4M 2P2
    CAN

    T: +1 514 484-4483

    E: [email protected]

    https://www.gud-knight.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    830

Stocks News & Analysis

stocks

Ask the analyst: Where does GYG stand following its US exit?

All roads lead back home for Guzman Y Gomez.
stocks

Chart of the Week: The long term headwinds facing copper shares

The key factors challenging the bull case for copper demand.
stocks

Australia’s oldest REIT undervalued

This REIT remains undervalued as trophy properties shine through.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,048.3074.600.83%
CAC 408,508.0733.210.39%
DAX 4025,779.31198.430.78%
Dow JONES (US)52,900.07594.831.14%
FTSE 10010,679.0326.160.25%
HKSE23,350.03295.001.28%
NASDAQ25,832.67207.36-0.80%
Nikkei 22569,744.071,010.921.47%
NZX 50 Index13,618.4236.230.27%
S&P 5007,483.240.010.00%
S&P/ASX 2008,844.4075.100.86%
SSE Composite Index4,043.6414.740.37%

Market Movers